Table 2. General characteristics of the AR(Eos), AR(Neu1), and AR(Neu2) groups.
Characteristics | AR(Eos) | AR(Neu1) | AR(Neu2) |
---|---|---|---|
No. | 22 | 22 | 22 |
Gender (male) | 12 (54.55) | 16 (72.73) | 17 (77.27) |
Age (year) | 15.59±11.53 | 15.86±13.31 | 15.82±12.24 |
History (year) | 2.83±2.09 | 3.08±2.29 | 3.13±2.45 |
Asthma (%) | 2 (9.10) | 3 (13.64) | 2 (9.10) |
VAS | 59.72±20.68 | 58.32±26.64 | 59.91±24.10 |
Nasal blockage* | 2.22±0.73 | 1.64±0.85 | 1.59±0.80 |
Nasal itching | 1.67±0.84 | 1.59±0.80 | 1.55±0.60 |
Nasal secretion | 1.72±0.75 | 1.73±0.83 | 1.77±0.75 |
Sneezing | 1.78±0.65 | 1.68±0.72 | 1.68±0.84 |
Total score | 7.39±2.03 | 6.64±2.17 | 6.59±2.04 |
Eos % | 91.01±13.36 | 4.73±4.15 | 3.86±4.08 |
Neu % | 8.99±13.36 | 95.27±4.15 | 96.14±4.08 |
Inflammation cell grades | 3.05±0.58 | 3.14±0.77 | 3.23±0.75 |
Data are shown as mean±SD or number (%).
AR, allergic rhinitis; VAS, visual analog scale; SD, standard deviation.
*The score of AR(Eos) was higher than that of AR(Neu1) (P=0.014) and AR(Neu2) (P=0.048).